Blog April 5, 2024 Biologics and Biosimilars Landscape: IP, Policy, and Market Developments Read more
Blog January 19, 2024 Middle District of North Carolina Finds Public Interest Favors Granting Preliminary Injunction Read more
Blog December 18, 2023 The Federal Circuit Weighs in On Hatch-Waxman “Skinny” Label Infringement Dispute Read more
Blog December 13, 2023 Legal Alert: Biden Administration Proposes March-In Rights Framework for Pharmaceutical Patents in Effort to Lower Drug Prices Read more